Hedgepath Pharmaceuticals Inc (HPPI) 0.2700

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Hedgepath Pharmaceuticals Inc (HPPI) 0.2700 $HPPI

BUYINS.NET Issues HedgePath Pharmaceuticals (HPPI) SqueezeTrigger Report
PR Newswire - Wed Jun 15, 7:00AM CDT
HedgePath Pharmaceuticals, Inc. (HPPI), a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer, announced today that BUYINS.NET, http://www.buyins.net/, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on HedgePath Pharmaceuticals (OTC: HPPI) after releasing the latest short sale data through June 10, 2016. The total aggregate number of shares shorted since August 2009 is approximately 4.6 million shares. Approximately 28.39% of total trading volume is short selling. The SqueezeTrigger price for all HPPI shares shorted is $0.298. A short squeeze is expected to begin when shares of HPPI cross above the $0.298 SqueezeTrigger Price.

FDA Grants Orphan Drug Designation to SUBA(TM)-Itraconazole for Treatment of Patients with BCCNS
PR Newswire - Thu Jun 02, 8:00AM CDT
HedgePath Pharmaceuticals, Inc. (OTCQB: HPPI), a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer, announced today that it has received notice of Orphan Drug Designation for treatment of patients with Basal Cell Carcinoma Nevus Syndrome (BCCNS) with its oral formulation of SUBA-Itraconazole Capsules.

HedgePath Pharmaceuticals Announces Completion of $5.5 Million Private Placement Offering
PR Newswire - Wed Jun 01, 8:00AM CDT
HedgePath Pharmaceuticals, Inc. (OTCQB: HPPI), a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer, announced today that it has completed its previously announced $5.5 million private placement offering. The company conducted the first closing of this offering on April 11, 2016. Offering expenses are estimated to be approximately $100,000.

HedgePath Pharmaceuticals Announces Commencement of Patient Treatment in its Phase II(b) Clinical Trial
PR Newswire - Tue Sep 29, 7:00AM CDT
HedgePath Pharmaceuticals, Inc. (OTCQB:HPPI), a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer, announced today that initial patients have received base-line screening and the first of those patients has begun dosing in HPPI's Phase II(b) clinical trial examining SUBA(TM) Itraconazole Capsules as a potential therapy for basal cell carcinoma (BCC) in patients with basal cell carcinoma nevus syndrome (BCCNS), also known as Gorlin's Syndrome.

HedgePath Pharmaceuticals To Receive $2.5 Million in Funding From Mayne Pharma
PR Newswire - Mon May 18, 8:00AM CDT
HedgePath Pharmaceuticals, Inc., (OTCQB: HPPI) a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer, announced today that it has entered into a definitive agreement with an affiliate of Mayne Pharma Group Limited (ASX: MYX) under which Mayne Pharma will invest $2.5 million in HPPI in a private common stock and warrant financing. The closing of the financing is expected to occur within five business days.

HedgePath Pharmaceuticals Receives IND Clearance to Commence Development of its Proposed Cancer Treatment
PR Newswire - Tue Dec 16, 8:00AM CST
HedgePath Pharmaceuticals, Inc. (OTCQB: HPPI), a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer, announced today that it received clearance of its first Investigational New Drug (IND) Application from the U.S. Food and Drug Administration (FDA).

HedgePath Pharmaceuticals Files IND Application
PR Newswire - Tue Nov 18, 8:00AM CST
HedgePath Pharmaceuticals, Inc. (OTCQB: HPPI), a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer, announced today that it filed an Investigational New Drug (IND) Application with the U.S. Food and Drug Administration (FDA) on Friday, November 14, 2014.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WIN Expands Leadership Amidst Rapid Growth Surge

Updated Category News Views 20

Why WIN's Leadership Shake-Up Matters Change is afoot at the fertility and family support powerhouse WIN, and there's no mistaking the bold handwriting on the wall. As they swell towards supporting one million families, WIN's revamping their leadership table with three key players aimed at pushing the envelope further than before. They've got Claudio Stefan, Stacey...

Continue Reading
AI-Powered Travel Transformation in Norway Revealed

Updated Category News Views 19

AI-Driven Travel Meets Norway's Authentic Charm Well, folks, once again we're staring down the barrel of technology going full throttle in the travel game. Mindtrip, the savvy AI-powered travel platform, just inked a deal with the Norwegian Travel Cluster. It's their first tango in Europe, and they're not dipping their toes—they're diving headfirst into the icy fjords....

Continue Reading
Cogent Communications' Q3 2026 Earnings Call Details

Updated Category News Views 10

Cue the Countdown: Cogent’s Earnings Call Looms Another quarter rolls by, and with it comes Cogent Communications' chance to strut—or stumble—before the crowd. Their third-quarter earnings call on November 5, 2026, is like the opening bell for a stock that's zipped through more ups and downs than a tired bullfighter's routine. What the call reveals on that crisp...

Continue Reading
Marshall Goldman Expands Footprint with Marino Acquisition

Updated Category News Views 27

Revving Up in Florida: Marshall Goldman's Strategic Leap If you're tuned into the luxury car scene, you probably already heard Marshall Goldman is making moves into Florida. Buying Marino Performance Motors of West Palm Beach isn't just another notch on their belt—it's a strategic leap into their second-largest market. This ain't merely about showroom floor space. Think...

Continue Reading
Wagner Logistics Gears Up for Major Expansion in Liberty

Updated Category News Views 20

Imagine waking up to news like this: Wagner Logistics is laying down some serious roots in Liberty, MO. They’ve snagged a deal with a local manufacturer that’s got them renting out over 830,000 square feet of warehouse space. Seems Wagner's got a knack for living large. More Than Just a Warehouse Gig Wagner's not just popping up another dusty shelf space; they're...

Continue Reading
Truck Drivers USA & Career Driver Unveil New Driver Agent

Updated Category News Views 31

Revolutionizing Driver-Carrier Connections In today's cranking transportation scene, Truck Drivers USA (TDUSA) and Career Driver have taken a bold step to change up the driver recruitment game. They've launched what's being labeled as the first 'driver agent' within the Career Driver mobile app. It's the talk of the town in Sherwood, Arkansas, these days. This isn't just...

Continue Reading
FCS Drives Key FDA Approvals in Cancer Treatment

Updated Category News Views 18

Florida Cancer Specialists: Changing the Cancer Treatment Game Some organizations toot their horns, but every now and then, a group truly shakes up the playing field. Take Florida Cancer Specialists & Research Institute (FCS), for instance. Over years of relentless research, FCS has nailed its role in securing two significant FDA approvals aimed at expanding treatment...

Continue Reading
JiMMYBAR! Unveils World's First Creatine Trail Mix

Updated Category News Views 17

The New Face of Snacking: Creatine Trail Mix I'll tell you right off the bat, JiMMYBAR! seems to be cornering the snack world with an odd—but interesting—twist. They've just launched the world's first Creatine + Protein Trail Mix, blending muscle-building nutrients with the classic crunch of trail mix. Sounds quirky, and it’s exclusive to their site, JiMMYBARs.com....

Continue Reading
A1 Refrigeration Keeps East Texas Homes Comfortable Year-Round

Updated Category News Views 27

Homeowners in East Texas would agree: the last thing you want is your HVAC system throwing a tantrum when you're in the thick of a scorching summer or a biting winter. That's where A1 Refrigeration & Air Conditioning steps in, making sure folks in Jasper, Brookeland, and Kirbyville aren't left sweating bullets or shivering in their boots. Preventive Maintenance: A...

Continue Reading
Tessa AI: Revolutionizing Biomedical Research with AI

Updated Category News Views 16

Shaking Up Research Evaluation When Siensmetrica decided it was high time for a name change, morphing into Tessa AI wasn't just a cosmetic shift. It was a nod to what stakeholders were already calling it and laid the ground for a broader mission statement. They're not sitting on their hands; they're crafting tools that tackle the scientific life cycle from start to...

Continue Reading

Top 5 Most Recently Viewed Articles

MGM Resorts Decides to Withdraw Casino License Application

Updated Category News Views 228

MGM Resorts Decides to Withdraw Casino License Application MGM Resorts International has made the strategic decision to withdraw its application for a commercial casino license. This move marks a significant moment for the company, reflecting a reassessment of its opportunities and direction in the competitive gaming and entertainment landscape. The decision underscores...

Continue Reading
Unlocking Crypto Profits: Explore PSMiner's Cloud Mining

Updated Category News Views 154

Introduction to PSMiner and Cloud Mining In the ever-evolving landscape of digital currencies, PSMiner is emerging as an innovative platform catering to both novice and seasoned investors. With the rise of blockchain technology and its adoption by major financial institutions, cryptocurrencies such as XRP, BTC, and ETH have captured significant attention. As traditional...

Continue Reading
Exploring Boliden's Growth in Minerals and Resources 2025

Updated Category News Views 119

Overview of Mineral Resource Growth in 2025 Boliden is experiencing a year of significant progress in mineral resource growth, underscored by successful exploration initiatives and improved economic assumptions. The operations across key areas like Garpenberg and the Boliden Area have demonstrated a robust increase in mineral resources, showcasing the company's...

Continue Reading
Strategic Acquisition of HPS Specialties by Ferguson Enterprises

Updated Category News Views 324

Trout Capital Advisors Supports HPS Specialties’ Exciting Sale Trout Capital Advisors has announced its role as the exclusive financial advisor to HPS Specialties, LLC, a top distributor of specialty engineered products for HVAC and plumbing. This exciting transaction marks a significant chapter for HPS as it transitions to Ferguson Enterprises Inc. (NYSE: FERG),...

Continue Reading
Investigation Paves Way for Bakkt Holdings' Shareholder Actions

Updated Category News Views 275

Faruqi & Faruqi, LLP Initiates Investigation on Bakkt Holdings Faruqi & Faruqi, LLP, a prominent national securities law firm, has embarked on an important investigation concerning Bakkt Holdings, Inc. (NYSE: BKKT). This inquiry focuses on potential claims on behalf of investors who may have faced financial losses in connection with their investments in Bakkt. Investors...

Continue Reading